A series of composites of PPO/PA 6 with improved toughness were synthesized by using ε‐caprolactam as a reactive solvent. Inserting minor PPO macromolecules (1–3 wt %) into PA 6 matrix obviously reduced the crystallinity of PA6. Two crystallization temperatures were found when 6 wt % PPO was added. SEM revealed that the phase morphology of the composites could be manipulated by varying the content of PPO in PA 6. As a consequence, the impact strength and the elongation of PPO/PA6 were improved with maintenance of tensile strength when quite small content of PPO (1–3 wt %) was incorporated.
No takes yet. Share an insight, caveat, or question.
Li et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: